Lecture 6 - Topo-microtubule Inhibitors Flashcards
Topoisomerase mechanisms
transcription and translation induce supercoiling
topoisomerases provide mechanism to reduce localized supercoiling and provide access to double stranded DNA by enzymes responsible for replication, transcription and repair
Topo1 inhibitors
irinotecan
Topo2 intercalator
doxorubicin
Topo2 inhibitors
etoposide
bleomycin
Topoisomerase 1
type I topoisomerase cut one strand of double stranded DNA, relax remaining strand and reanneal
Topoisomerase I inhibitor mechanism
inhibitor covalently attached to enzyme that is covalently attached to DNA, blocks religation from occurring
provides physical barrier to replication and transcription, prevent DNA from being functional
Topoisomerase I inhibitors
S phase specific! - cells in S phase are most sensitive to Topo I induced cleavage
bind to and form a ternary drug-enzyme-DNA complex, glues topoisomerase to DNA
inhibitor binding stabilizes Topo-DNA complex and blocks DNA religation
Topoisomerase I inhibitor drug resistance
PGP overexpression, multidrug resistant protein overexpression, topoisomerase downregulation or mutation to prevent inhibitor binding
Topoisomerase I inhibitors - camptothecins
topotecan and irinotecan
Irinotecan
is a prodrug, irinotecan converted to SN-38 (active metabolite) by carboxylesterases
SN-38 is metabolized by uridine diphospate glucosyltransferase (UGT1A1)
~10% of the pop has polymorphisms predicting low expression of UGT1A1, leading to increased toxicity of irinotecan
Topoisomerase II relieves
torsional strain and untangles DNA by catalyzing double-stranded DNA breaks
Topoisomerase II inhibitors
doxorubicin
etoposide
non-cell cycle dependent, although activity is greater in G2/M
Doxorubicin
toxicity: cardiotoxicity - damage to cardiac muscle dependent on cumulative dose; severe local tissue damage if extravastated
free radical damage causes cardiotoxicity since heart tissue has low levels of enzymes that neutralize free radicals
Dexrazoxane
drug to mediate toxicity, helps to manage cardiac damage; protects against anthracycline-induced cardiotoxicity
cyclic analog of metal chelating agent EDTA
enters cell and converts to ring-opened chelating agent - binds to iron, blocks iron-oxygen induced toxicities; cardiotoxicity of doxorubicin believed to be caused by iron-catalyzed free radical formation
Etoposide
inhibits religation of double stranded breaks induced by topoII but does not intercalate
G2 block-cell cycle specific
produces G2/M block